Committee

The STEMPA Initiative was established under the direction of the Human Health and Potential (HHP) executive committee (EXCO).

It is the result of a collaboration across institutions in Singapore, including the three public healthcare clusters, institutes of higher learning, Agency for Science, Technology and Research (A*STAR), and Consortium for Clinical Research and Innovation, Singapore (CRIS) units. Representatives from research, legal, and contracts management functions across these institutions have worked together to identify the causes of project agreement delays and develop the recommendations implemented under STEMPA.

Grantor agencies, including the National Medical Research Council (NMRC) and the Office of Grants Administration under A*STAR, have also been closely involved as observers of the STEMPA conversation and implementation process.

All STEMPA recommendations have been endorsed by the HHP EXCO and senior leadership of Singapore’s public sector institutions.